Vanda Pharmaceuticals
VSJ-110
Dry Eye
Countdown
86days
Phase 2 readout · ~ Sep 30, 2026 estimated
What's at stake
Phase 2 trial results for VSJ-110 in Dry Eye are due ~ Sep 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 13h ago
“CT.gov NCT07179055: Phase 2 trial, sponsor Vanda Pharmaceuticals, drug VSJ-110. Primary completion date 2026-09 (estimated).”